Fermenta Biotech Limited (FERMENTA) Financial History

Name: Fermenta Biotech Limited (FERMENTA) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Fermenta Biotech Limited (FERMENTA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Thane, India with about 630 employees. Its market capitalization is roughly ₹14 billion. In the fiscal year ended 2026-03-31, FERMENTA reported ₹5.2B in revenue and ₹718M in net income.

Fermenta Biotech Limited, together with its subsidiaries, engages in the manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products in India, Europe, the United States, and internationally.

Interactive charts & full statements →

FERMENTA Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹5.2B	₹4.7B	₹3.3B	₹3.5B
Gross Profit	₹3.1B	₹2.9B	₹1.9B	₹1.9B
Operating Income (EBIT)	₹828M	₹934M	₹94M	(₹10M)
Net Income	₹718M	₹769M	(₹231M)	(₹511M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

FERMENTA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹1.2B	₹1.2B	₹1.4B	₹1.3B	₹1.4B	—
Gross Profit	₹798M	₹799M	₹857M	₹837M	₹843M	—
Operating Income (EBIT)	₹129M	₹149M	₹196M	₹212M	₹224M	—
Net Income	₹97M	₹192M	₹127M	₹189M	₹218M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

FERMENTA Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹73M)	(₹36M)	(₹36M)	(₹42M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

FERMENTA Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹6.5B	₹6.1B	₹5.5B	₹6.4B	—
Total Liabilities	₹2.5B	₹2.6B	₹2.6B	₹3.2B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FERMENTA viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

3933 · The United Laboratories International Holdings Limited — HK$16 billion
2637 · Fujian Haixi Pharmaceuticals Co., Ltd. — HK$15 billion
JAGSNPHARM · Jagsonpal Pharmaceuticals Limited — ₹15 billion
AMRUTANJAN · Amrutanjan Health Care Limited — ₹14 billion
4574 · Taiko Pharmaceutical Co.,Ltd. — JPY 13 billion
IPN · Ipsen S.A. — €13 billion
AHCL · Anlon Healthcare Limited — ₹12 billion
LINCOLN · Lincoln Pharmaceuticals Limited — ₹12 billion

← FERGR All “F” companies FESC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.